Jaideep Dudani
Private Equity Investor chez Monograph Capital Advisors (UK) LLP
Postes actifs de Jaideep Dudani
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Private Equity Investor | 01/07/2021 | - |
Historique de carrière de Jaideep Dudani
Anciens postes connus de Jaideep Dudani
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RELAY THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2019 | 30/06/2021 |
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Consultant / Advisor | 01/01/2018 | 31/03/2018 |
Formation de Jaideep Dudani
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Private Equity Investor | 1 |
| Corporate Officer/Principal | 1 |
| Consultant / Advisor | 1 |
Sectorielle
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RELAY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Finance |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Jaideep Dudani
- Expérience
